Evidence map›Paper›PMID 42851181›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2026

[Clinical analysis of nine pediatric cases of acute myeloid leukemia with NUP98 rearrangement].

C M Wang, X P Jia, J Luo, Y S Zhang, X J Xu, B Li, D Wang, Q H Yao, G Y Sheng

Abstract readEnglish Abstract
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

C M WangDepartment of Pediatric Hematology and Oncology, Children's Hospital of First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
X P JiaDepartment of Pediatric Hematology and Oncology, Children's Hospital of First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
J LuoDepartment of Pediatric Hematology and Oncology, Children's Hospital of First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Y S ZhangDepartment of Pediatric Hematology and Oncology, Children's Hospital of First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
X J XuDepartment of Pediatric Hematology and Oncology, Children's Hospital of First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
B LiDepartment of Pediatric Hematology and Oncology, Children's Hospital of First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
D WangDepartment of Pediatric Hematology and Oncology, Children's Hospital of First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Q H YaoDepartment of Pediatric Hematology and Oncology, Children's Hospital of First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
G Y ShengDepartment of Pediatric Hematology and Oncology, Children's Hospital of First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A retrospective case analysis was conducted on nine newly diagnosed pediatric patients with NUP98-rearranged acute myeloid leukemia (AML) who were admitted to the First Affiliated Hospital of Zhengzhou University between January 2019 to June 2025. Nine patients (3 males and 6 females) accounted for 4.2% of the 214 children diagnosed with AML during the same period. The patients' median age at diagnosis was 7 years (range: 8 months to 14 years). This type of AML was classified as M

Indexed as

Leukemia, Myeloid, AcuteNuclear Pore Complex ProteinsAdolescentChildChild, PreschoolFemaleGene RearrangementHematopoietic Stem Cell TransplantationHumansInfantMaleMutationOncogene Proteins, FusionRetrospective StudiesNuclear Pore Complex ProteinsNup98 protein, humanOncogene Proteins, Fusion

Identifiers

PMID42851181
PMCPMC13669434

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.